Alfa-Laval BTPX 305 SGD-34 CDEP pilot biotech clarifier skid, 316L SS.

Max bowl speed 9650 RPM, 12,800 x G, steam sterilizable, gastight, liquid phase discharged under pressure, jacketed bowl, 7.5 KW motor 380/480/3/50/60/1500 RPM, sludge tank, flow meter, lobe pump, PLC control panel with Panel View 1000 interface, tools and manuals, unitized an a SS skid. Prior use: Pharma. 2006 vintage. Excellent condition.

The Alfa-Laval BTPX 305 SGD-34 CDEP pilot biotech clarifier skid, 316L SS. is engineered for high-performance separation processes, particularly suited for the pharmaceutical industry. With a maximum bowl speed of 9650 RPM and generating an impressive 12,800 x G, this clarifier is designed to efficiently separate solids from liquids, ensuring high purity and clarity in the final product. The steam sterilizable feature enhances its usability in sterile environments, making it an ideal choice for biotech applications where contamination control is paramount. The gastight design further ensures that the process remains secure, preventing any unwanted exposure to the environment and maintaining the integrity of the materials being processed.

In addition to its robust performance specifications, the Alfa-Laval BTPX 305 is equipped with a jacketed bowl that allows for temperature control during operation, which is critical for sensitive biotech processes. The unit is powered by a 7.5 KW motor, compatible with multiple voltage configurations (380/480/3/50/60/1500 RPM), providing flexibility for various installation requirements. The inclusion of a sludge tank, flow meter, and lobe pump enhances the overall functionality of the skid, allowing for precise monitoring and control of the separation process. The integrated PLC control panel with a Panel View 1000 interface simplifies operation, providing users with an intuitive platform for managing settings and monitoring performance. This unit, manufactured in 2006, has been maintained in excellent condition, making it a reliable choice for companies looking to enhance their biotech processing capabilities.